Stock Market Reviews

ITGR (Integer Holdings Corporation) News

Get the latest news, insights, and market updates on ITGR (Integer Holdings Corporation). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Integer to Participate at Upcoming Investor Conferences
  PLANO, Texas, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, announced today that members of its executive leadership team will participate at the following investor conferences in December: Piper Sandler 37th Annual Healthcare Conference at 8:00 a.m. ET on Tuesday, Dec. 2Citi’s 2025 Global Healthcare Conference at 9:45 a.m. ET on Wednesday, Dec. 3 A live webcast and replay for each event
  Nov 18, 2025 - $ITGR
• Integer Holdings (ITGR): Assessing Value After $200 Million Share Buyback Announcement
  Integer Holdings (ITGR) just unveiled a $200 million share repurchase program, planning to use existing cash and free cash flow for the buybacks. Investors often see these programs as a sign of management’s confidence. See our latest analysis for Integer Holdings. Integer Holdings’ announcement of a $200 million buyback comes as shareholders weather a tough stretch, with a year-to-date share price return of -48.35% and a 1-year total return of -51.06%. While recent days saw a slight rebound,...
  Nov 10, 2025 - $ITGR
• Q3 Earnings Highlights: Integer Holdings (NYSE:ITGR) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
  Looking back on medical devices & supplies - specialty stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Integer Holdings (NYSE:ITGR) and its peers.
  Nov 10, 2025 - $ITGR
• Integer Holdings (ITGR) Is Up 5.7% After Authorizing US$200 Million Stock Buyback – Has The Bull Case Changed?
  Integer Holdings Corporation recently announced a share repurchase program, authorizing the buyback of up to US$200 million of its common stock using cash on hand and free cash flow, with no expiration date set. This initiative can indicate management's confidence in the company's financial health and long-term prospects, frequently viewed as shareholder-friendly. We'll explore how Integer's new US$200 million share repurchase program may affect the company's investment thesis and future...
  Nov 9, 2025 - $ITGR
• Ultralife Corporation Files Form 12b-25 Notification of Late Filing
  NEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Form 10-Q for the third quarter ended September 30, 2025. As previously disclosed, on October 31, 2024, Ultralife completed its acquisition of all outstanding shares of Electrochem Solutions, Inc. (“Electrochem”) from Integer Holdings Corporation (“Integer”). During the
  Nov 7, 2025 - $ITGR
• Integer Holdings Corporation Board Authorizes $200 Million Share Repurchase Program
  PLANO, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced that its Board of Directors has authorized a share repurchase program of up to $200 million of the Company’s outstanding common stock. “This share repurchase program reflects the confidence of the Board and management in our strategy, financial position, and ability to generate strong free cash flows,” said Payman
  Nov 4, 2025 - $ITGR
• 5 Revealing Analyst Questions From Integer Holdings’s Q3 Earnings Call
  Integer Holdings’ third quarter results were overshadowed by management’s acknowledgment of unexpected headwinds tied to lower-than-anticipated adoption of several new products. CEO-elect Payman Khales explained that multiple customers revised their forecasts downward, impacting both the Cardio & Vascular and Neuromodulation product lines. These customer-driven changes, which management described as “highly unusual,” led to a reduction in the company’s full-year outlook. Khales clarified, “We re
  Oct 30, 2025 - $ITGR
• Here's Why Integer (ITGR) is a Strong Growth Stock
  Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
  Oct 27, 2025 - $ITGR
• Integer Holdings (ITGR): Valuation Update Following Lowered 2025 Outlook and Revised Long-Term Growth Guidance
  Shares of Integer Holdings, a medical technology company, dropped sharply after it lowered its full-year 2025 revenue and EBITDA forecast following third quarter results. Profitability fell short, even though revenue met expectations. See our latest analysis for Integer Holdings. Investor confidence in Integer Holdings has been rattled in recent weeks, with shares sliding over 30% in just the last week and the latest one-day drop reflecting a steep reaction to lowered financial guidance. Even...
  Oct 27, 2025 - $ITGR
• Integer price target lowered to $95 from $143 at Raymond James
  Raymond James lowered the firm’s price target on Integer (ITGR) to $95 from $143 and keeps an Outperform rating on the shares after the stock tumbled 32% on news of headwinds from three customers limiting 2026 organic growth to LSD. The update came as a surprise to investors who were already skittish into the print, which actually saw reasonably solid Q3 results, the firm says. Sensitivity to customer confidentiality limits clarity, and Raymond thinks has further hindered the stock. While frustr
  Oct 25, 2025 - $ITGR